Literature DB >> 7505108

Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.

R D Brines1, G G Klaus.   

Abstract

It is well-established that preactivated CD4+ T cells can activate mature B cells in a polyclonal, MHC-unrestricted fashion. We have used this system to investigate the effects of T cell-derived signals on immature B cells purified from the spleens of neonatal mice, since these cells are unresponsive to many polyclonal activators and are exquisitely sensitive to tolerization. We show that immature B cells can be induced to proliferate by anti-CD3 activated, fixed Th1 and Th2 cells, although the latter induce a greater response than the former. Antibodies to IL-4 partially blocked stimulation by Th2 cells, whereas antibodies to IL-2 and IL-5 had no effect on responses to Th1 cells. This suggested that molecules in addition to IL-4 contribute to the capacity of T cells to induce B cell activation, one likely candidate being the ligand for CD40. We therefore generated mouse erythroleukemia (MEL) transfectants which express CD40 ligand (CD40L). These transfectants also induced proliferation of immature B cells, which is enhanced by IL-4. Unlike the situation with mature B cells, both anti-mu and anti-delta antibodies inhibited the activation of immature B cells by CD40L-MEL cells. However, this inhibition was reversed by IL-4, which synergized with signals delivered through CD40 to render immature B cells refractory to negative signals delivered through sIg. Taken together these data suggest that immature B cells can be activated by T cell-derived contact signals and that CD40L-CD40 interactions, in the presence of IL-4, are capable of abrogating the negative signals generated via sIgM and sIgD receptors expressed by these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505108     DOI: 10.1093/intimm/5.11.1445

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Transcriptome Analysis of Mycobacteria-Specific CD4+ T Cells Identified by Activation-Induced Expression of CD154.

Authors:  Shajo Kunnath-Velayudhan; Michael F Goldberg; Neeraj K Saini; Christopher T Johndrow; Tony W Ng; Alison J Johnson; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2017-08-18       Impact factor: 5.422

2.  Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice.

Authors:  S Marshall-Clarke; G Owen; L Tasker
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

3.  IgD ligation allows peritoneal cavity B cell proliferation.

Authors:  Jennifer Londregan; Jeffrey Maslanka; Naomi Goldman; John Somerville; James E Riggs
Journal:  Immunobiology       Date:  2022-01-20       Impact factor: 3.144

4.  Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice.

Authors:  K J Erb; B Rüger; M von Brevern; B Ryffel; A Schimpl; K Rivett
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

5.  Functional silencing is initiated and maintained in immature anti-insulin B cells.

Authors:  Rachel A Henry; Carlos A Acevedo-Suárez; James W Thomas
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy.

Authors:  Li Li; Dan Qiao; Xiaoying Fu; Suihua Lao; Xianlan Zhang; Changyou Wu
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

7.  Activated CD4+ T cells enter the splenic T-cell zone and induce autoantibody-producing germinal centers through bystander activation.

Authors:  David Banczyk; Kathrin Kalies; Lars Nachbar; Lars Bergmann; Philipp Schmidt; Ulrike Bode; Bianca Teegen; Philipp Steven; Tanja Lange; Johannes Textor; Ralf J Ludwig; Winfried Stöcker; Peter König; Eric Bell; Jürgen Westermann
Journal:  Eur J Immunol       Date:  2013-11-04       Impact factor: 5.532

8.  Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.

Authors:  F R Donís-Hernández; R M Parkhouse; L Santos-Argumedo
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

9.  Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.

Authors:  Arun V Iyer; Bapi Pahar; Marc J Boudreaux; Nobuko Wakamatsu; Alma F Roy; Vladimir N Chouljenko; Abolghasem Baghian; Cristian Apetrei; Preston A Marx; Konstantin G Kousoulas
Journal:  Vaccine       Date:  2008-12-12       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.